In Chinese drug quality audits, complaints and recalls are managed through a structured process involving investigation, risk assessment, and corrective actions. Regulatory bodies, like the National Medical Products Administration, oversee compliance. Manufacturers must promptly report issues, initiate recalls if necessary, and implement preventive measures to ensure product safety and quality.
